SNT syntara limited
Add to My Watchlist 0.00% ! 5.1¢

Syntara the science explained, page-217

  1. pinch2020
    922 Posts.
    lightbulb Created with Sketch. 580
    clock Created with Sketch.
    10/12/24
    09:26
    Post #: 76978581
    This should keep it pretty simple.

    "Our conversations with key opinion leaders in myelofibrosis indicated that they would like to see 20% for SVR35 and 30% TSS50 as the benchmark for a ‘good result’ in this patient population"
    SNT Price at posting: 6.7¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 10  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NUZ Liquid Formulation of NUZ-001 Developed to Improve Patient Access and Experience
right-arrow Created with Sketch.
NEWS Progress in Phelan-McDermid Syndrome Program to Be Presented at PMS Global Congress
right-arrow Created with Sketch.
NEWS Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back
right-arrow Created with Sketch.
CLA Celsius Resources Commences FEED and Feasibility Study at MCB Project Site
right-arrow Created with Sketch.
NEWS 30,000m Diamond Drilling Commences at Napie Gold Project
right-arrow Created with Sketch.
NEWS High-Grade Scandium Assays Returned at Syerston from Drilling Campaign
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
5.1¢ 		Change
0.000(0.00%) 		Mkt cap ! $82.87M
Open High Low Value Volume
5.1¢ 5.4¢ 5.1¢ $107.2K 2.071M

Buyers (Bids)

No. Vol. Price($)
2 534937 5.1¢
 

Sellers (Offers)

Price($) Vol. No.
5.3¢ 18846 1
View Market Depth
Last trade - 16.10pm 27/06/2025 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.